1194 related articles for article (PubMed ID: 36297117)
1. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
Chen J; Zhou H; Jin H; Liu K
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis.
Yang S; Pudasaini R; Zhi H; Wang L
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011056
[TBL] [Abstract][Full Text] [Related]
3. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
[TBL] [Abstract][Full Text] [Related]
4. The Association between Circulating Lipids and Female Infertility Risk: A Univariable and Multivariable Mendelian Randomization Analysis.
Zhu X; Hong X; Wu J; Zhao F; Wang W; Huang L; Li J; Wang B
Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513548
[TBL] [Abstract][Full Text] [Related]
5. The association between telomere length and blood lipids: a bidirectional two-sample Mendelian randomization study.
Yang S; Wang X; Li Y; Zhou L; Guo G; Wu M
Front Endocrinol (Lausanne); 2024; 15():1338698. PubMed ID: 38863926
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
[TBL] [Abstract][Full Text] [Related]
7. The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
Huang Q; Guo J; Zhao H; Zheng Y; Zhang Y
PLoS One; 2023; 18(10):e0292881. PubMed ID: 37856513
[TBL] [Abstract][Full Text] [Related]
8. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
Liang Z; Zhao L; Lou Y; Liu S
QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
[TBL] [Abstract][Full Text] [Related]
9. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
[TBL] [Abstract][Full Text] [Related]
10. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
11. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study.
Han X; Ong JS; Hewitt AW; Gharahkhani P; MacGregor S
Int J Epidemiol; 2021 Mar; 50(1):325-336. PubMed ID: 33211829
[TBL] [Abstract][Full Text] [Related]
12. Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Zhang Z; Li M; Ji G; Zhang L
Eur J Clin Invest; 2024 Mar; 54(3):e14116. PubMed ID: 37916519
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of serum lipids and lipid-modifying targets with endometriosis: Trans-ethnic Mendelian-randomization and mediation analysis.
Zhang H; Fan Y; Li H; Feng X; Yue D
PLoS One; 2024; 19(5):e0301752. PubMed ID: 38820493
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
16. Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study.
Tremblay M; Perrot N; Ghodsian N; Gobeil É; Couture C; Mitchell PL; Thériault S; Arsenault BJ
J Clin Endocrinol Metab; 2021 Jul; 106(8):e3178-e3184. PubMed ID: 33693708
[TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization study of lipid metabolism characteristics and migraine risk.
Hong P; Han L; Wan Y
Eur J Pain; 2024 Jul; 28(6):978-986. PubMed ID: 38183343
[TBL] [Abstract][Full Text] [Related]
18. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
Tan Z; Hong J; Sun A; Ding M; Shen J
Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
[TBL] [Abstract][Full Text] [Related]
19. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
[TBL] [Abstract][Full Text] [Related]
20. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
